SGH
IRWD icon

Sivik Global Healthcare’s Ironwood Pharmaceuticals IRWD Stock Holding History

Sivik Global Healthcare’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-89,550
Closed -$1.2M – 75
2015
Q1 		$1.2M Buy
+89,550
New +$1.17M 0.41% 71

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Sivik Global Healthcare's IRWD Position: Q2 2015 in Review

Sivik Global Healthcare sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2015, closing a stake of 89,550 shares — an estimated $1.2M sold.

Sivik Global Healthcare first reported a position in IRWD in Q1 2015 and held it in 1 quarter. The position peaked at $1.2M in Q1 2015. 137 funds tracked by Wall St. Rank hold IRWD as of Q2 2015.

  • Sivik Global Healthcare reported no remaining Ironwood Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Sivik Global Healthcare sold 89,550 Ironwood Pharmaceuticals shares in Q2 2015, an estimated $1.2M.
  • Sivik Global Healthcare first reported a position in Ironwood Pharmaceuticals in Q1 2015 and held it in 1 quarter.
  • Sivik Global Healthcare's Ironwood Pharmaceuticals position peaked at $1.2M in Q1 2015.
  • 137 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2015.

Based on Sivik Global Healthcare's 13F filing for Q2 2015, filed 6 Jul 2015.